Inventor · disambiguated record
Koji Takano
Also filed as: TAKANO KOJI
7 granted patents·5 pending applications·35 citations·filing 2006–2025
80Inventor score
Top patents by PatentIndex Score
12 records- 0195US11891457B2Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 6, 2024·12 cites·14 claims
- 0293US12415835B2Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·1 cites·21 claims
- 0393US9409952B2Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Granted Aug 9, 2016·20 cites·54 claims
- 0481US12371454B2Cyclic peptide compound having Kras inhibitory actionCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jul 29, 2025·0 cites·12 claims
- 0575US12410212B2Cyclic compound having selective KRAS inhibitory effect on HRAS and NRASCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Sep 9, 2025·0 cites·24 claims
- 0670US9163051B2Crystal of spiroketal derivatives and process for preparation of spiroketal derivativesCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Oct 20, 2015·2 cites·7 claims
- 0757US2016311858A1Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 0856US2024148821A1Pharmaceutical use of cyclic peptide compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0954US2025230193A1Cyclic compound having selective kras inhibitory effect on hras and nrasCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1054US2023151060A1Cyclic peptide compound having kras inhibitory actionCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1152US2024158446A1Cyclic compound having selective inhibitory action on kras over hras and nrasCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1246US8173824B2Process for producing vitamin D derivative using convergent methodOGASAWARA KUNIO·Filed 2006·Granted May 8, 2012·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Koji Takano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →